Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ancarani

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
Molecular Therapy. Methods & Clinical Development|June 5, 2023
Analysis of EVs from patients with advanced pancreatic cancer identifies antigens and miRNAs with predictive valueIvan Vannini, Tania Rossi, Mattia Melloni, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita|November 11, 2020
Screening program for latent tuberculosis infection in asylum seekers - a single center experience in Pavia, ItalyC Grecchi, C Sarda, T Manciulli, et al.
BMJ Open|August 8, 2018
Complementary vaccination protocol with dendritic cells pulsed with autologous tumour lysate in patients with resected stage III or IV melanoma: protocol for a phase II randomised trial (ACDC Adjuvant Trial)Laura Ridolfi, Francesco de Rosa, Laura Fiammenghi, et al.
HLA|January 14, 2025
Exploring the Relationship Between Humoral and Cellular T Cell Responses Against SARS-CoV-2 in Exposed Individuals From Emilia Romagna Region and COVID-19 SeverityLucia Mazzotti, Patricia Borges de Souza, Irene Azzali, et al.
Epidemiologia E Prevenzione|May 21, 2024
Disparities in access to breast, colorectal, and cervical cancer screening programmes have intensified during the pandemic period. Findings of a health equity audit conducted by the Pavia Healthcare Protection Agency (Lombardy Region, Northern Italy)Daniela Girardi, Riccardo Vecchio, Marina Tanious, et al.
Frontiers in Immunology|October 26, 2019
Dendritic Cell Vaccination in Metastatic Melanoma Turns "Non-T Cell Inflamed" Into "T-Cell Inflamed" TumorsJenny Bulgarelli, Marcella Tazzari, Anna Maria Granato, et al.
Journal of Translational Medicine|June 4, 2013
Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patientsLaura Ridolfi, Massimiliano Petrini, Anna Maria Granato, et al.
Journal of Translational Medicine|July 24, 2014
Vaccination with autologous dendritic cells loaded with autologous tumor lysate or homogenate combined with immunomodulating radiotherapy and/or preleukapheresis IFN-α in patients with metastatic melanoma: a randomised "proof-of-principle" phase II studyFrancesco de Rosa, Laura Ridolfi, Ruggero Ridolfi, et al.
Melanoma Research|June 28, 2017
Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experienceFrancesco de Rosa, Laura Ridolfi, Laura Fiammenghi, et al.
Frontiers in Immunology|June 5, 2026
CORSA study finds spike-specific blunted immune responses in lymphoma patients after SARS-CoV-2 vaccineLucia Mazzotti, Gerardo Musuraca, Fabio Affaticati, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Molecular Therapy. Methods & Clinical Development|June 5, 2023
Analysis of EVs from patients with advanced pancreatic cancer identifies antigens and miRNAs with predictive valueIvan Vannini, Tania Rossi, Mattia Melloni, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita|November 11, 2020
Screening program for latent tuberculosis infection in asylum seekers - a single center experience in Pavia, ItalyC Grecchi, C Sarda, T Manciulli, et al.
BMJ Open|August 8, 2018
Complementary vaccination protocol with dendritic cells pulsed with autologous tumour lysate in patients with resected stage III or IV melanoma: protocol for a phase II randomised trial (ACDC Adjuvant Trial)Laura Ridolfi, Francesco de Rosa, Laura Fiammenghi, et al.
HLA|January 14, 2025
Exploring the Relationship Between Humoral and Cellular T Cell Responses Against SARS-CoV-2 in Exposed Individuals From Emilia Romagna Region and COVID-19 SeverityLucia Mazzotti, Patricia Borges de Souza, Irene Azzali, et al.
Epidemiologia E Prevenzione|May 21, 2024
Disparities in access to breast, colorectal, and cervical cancer screening programmes have intensified during the pandemic period. Findings of a health equity audit conducted by the Pavia Healthcare Protection Agency (Lombardy Region, Northern Italy)Daniela Girardi, Riccardo Vecchio, Marina Tanious, et al.
Frontiers in Immunology|October 26, 2019
Dendritic Cell Vaccination in Metastatic Melanoma Turns "Non-T Cell Inflamed" Into "T-Cell Inflamed" TumorsJenny Bulgarelli, Marcella Tazzari, Anna Maria Granato, et al.
Journal of Translational Medicine|June 4, 2013
Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patientsLaura Ridolfi, Massimiliano Petrini, Anna Maria Granato, et al.
Journal of Translational Medicine|July 24, 2014
Vaccination with autologous dendritic cells loaded with autologous tumor lysate or homogenate combined with immunomodulating radiotherapy and/or preleukapheresis IFN-α in patients with metastatic melanoma: a randomised "proof-of-principle" phase II studyFrancesco de Rosa, Laura Ridolfi, Ruggero Ridolfi, et al.
Melanoma Research|June 28, 2017
Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experienceFrancesco de Rosa, Laura Ridolfi, Laura Fiammenghi, et al.
Frontiers in Immunology|June 5, 2026
CORSA study finds spike-specific blunted immune responses in lymphoma patients after SARS-CoV-2 vaccineLucia Mazzotti, Gerardo Musuraca, Fabio Affaticati, et al.
Pageof 10